"The Effect of Inhaled Nitroglycerin for COPD Patients

Recruiting now · Phase 2/Phase 3

Conditions studied: COPD, COPD III/IV

In brief

this study aims to investigative the benefits of using nebulized nitroglycerin in improving respiratory functions in patients of late stage COPD

Key facts

Study ID

NCT06785337

Run by

Beni-Suef University

People needed

40

Starts

2025-02-01

Expected to finish

2025-12-01

Last updated by the study team

2025-01-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patient's ≥ 18 years old COPD exacerbation with respiratory failure and Echo evidenced presence of pulmonary hypertension (defined as mean pulmonary artery pressure > 20 mmHg)

You may not qualify if…

• Profound left ventricular failure, as the decrease in pulmonary vascular resistance results in an increase in left ventricular preload. This may worsen cardiogenic pulmonary edema.
• Pregnant female patients
• Patient with hypersensitivity to nitroglycerin

Where it is running

• Haram Hospital — Haram, Giza Governorate, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.